These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11469615)

  • 1. Dual test diabetes screening project: screening for poor glycemic control in a large workplace population.
    Carter AW; Borchardt N; Cooney M; Greene D
    Diabetes Technol Ther; 2000; 2(4):529-36. PubMed ID: 11469615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-test monitoring of hyperglycemia using daily glucose and weekly fructosamine values.
    Carter AW; Borchardt N; Cooney M; Greene D
    Diabetes Technol Ther; 2001; 3(3):399-403. PubMed ID: 11762518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of fructosamine levels in a multi-ethnic Sub-Saharan African population.
    Nouya AY; Nansseu JR; Moor VJ; Pieme CA; Noubiap JJ; Tchoula CM; Mokette BM; Takam RD; Tankeu F; Ngogang JY; Kengne AP
    Diabetes Res Clin Pract; 2015 Jan; 107(1):123-9. PubMed ID: 25458342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for diabetes: does measurement of serum fructosamine help?
    Swai AB; Harrison K; Chuwa LM; Makene W; McLarty D; Alberti KG
    Diabet Med; 1988 Oct; 5(7):648-52. PubMed ID: 2975548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test.
    Herdzik E; Safranow K; Ciechanowski K
    Acta Diabetol; 2002 Apr; 39(1):15-22. PubMed ID: 12043934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine).
    Edelman SV; Callahan P; Deeb LC
    Diabetes Technol Ther; 2000; 2(2):233-8. PubMed ID: 11469264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care.
    Lindsey CC; Carter AW; Mangum S; Greene D; Richardson A; Brown SJ; Essary JL; McCandless B
    Diabetes Technol Ther; 2004 Jun; 6(3):370-7. PubMed ID: 15198841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening.
    Tsuji I; Nakamoto K; Hasegawa T; Hisashige A; Inawashiro H; Fukao A; Hisamichi S
    Diabetes Care; 1991 Nov; 14(11):1075-7. PubMed ID: 1797489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting.
    Kengne AP; Erasmus RT; Levitt NS; Matsha TE
    Prim Care Diabetes; 2017 Apr; 11(2):119-131. PubMed ID: 28132763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and ethnic differences in glycemic control of adults with type 2 diabetes.
    Harris MI; Eastman RC; Cowie CC; Flegal KM; Eberhardt MS
    Diabetes Care; 1999 Mar; 22(3):403-8. PubMed ID: 10097918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of biphasic insulin aspart 70/30 in type 2 diabetes patients of different race or ethnicity (INITIATEplus trial).
    Trippe BS; Shepherd MD; Coulter FC; Bhargava A; Brett J; Chu PL; Oyer DS
    Curr Med Res Opin; 2012 Jul; 28(7):1203-11. PubMed ID: 22509859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic/racial determinants of glycemic markers in a UK sample.
    Shipman KE; Jawad M; Sullivan KM; Ford C; Gama R
    Acta Diabetol; 2015 Aug; 52(4):687-92. PubMed ID: 25559352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fructosamine measurement for diabetes mellitus diagnosis and monitoring: a systematic review and meta-analysis protocol.
    Nansseu JR; Fokom-Domgue J; Noubiap JJ; Balti EV; Sobngwi E; Kengne AP
    BMJ Open; 2015 May; 5(5):e007689. PubMed ID: 25979870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nonfasting tests to screen for childhood and adolescent dysglycemia.
    Lee JM; Gebremariam A; Wu EL; LaRose J; Gurney JG
    Diabetes Care; 2011 Dec; 34(12):2597-602. PubMed ID: 21953800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, multicentered controlled trial to compare the annual outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care: a 3-month interim analysis.
    Lindsey CC; Carter AW; Mangum S; Greene D; Richardson A; Brown S; McCandless B
    Diabetes Technol Ther; 2002; 4(5):637-42. PubMed ID: 12450445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of fructosamine for monitoring outpatients with diabetes.
    Austin GE; Wheaton R; Nanes MS; Rubin J; Mullins RE
    Am J Med Sci; 1999 Nov; 318(5):316-23. PubMed ID: 10555094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort.
    Malmström H; Walldius G; Grill V; Jungner I; Gudbjörnsdottir S; Hammar N
    PLoS One; 2014; 9(10):e111463. PubMed ID: 25353659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fructosamine as a marker of 5-year risk of developing diabetes mellitus in patients exhibiting stress hyperglycaemia.
    Wahid ST; Sultan J; Handley G; Saeed BO; Weaver JU; Robinson AC
    Diabet Med; 2002 Jul; 19(7):543-8. PubMed ID: 12099956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.